Background: In early stages of idiopathic Parkinson's disease (IPD), lower order vision (LOV) deficits including reduced colour and contrast discrimination have been consistently reported. Data are less conclusive concerning higher order vision (HOV) deficits, especially for facial emotion recognition (FER). However, a link between both visual levels has been hypothesized. Objective: To screen for both levels of visual impairment in early IPD. Methods: We prospectively recruited 28 IPD patients with disease duration of 1.4 +/− 0.8 years and 25 healthy controls. LOV was evaluated by Farnsworth-Munsell 100 Hue Test, Vis-Tech and Pelli-Robson test. HOV was examined by the Ekman 60 Faces Test and part A of the Visual Object and Space recognition test. Results: IPD patients performed worse than controls on almost all LOV tests. The most prominent difference was seen for contrast perception at the lowest spatial frequency (p = 0.0002). Concerning FER IPD patients showed reduced recognition of "sadness" (p = 0.01). "Fear" perception was correlated with perception of low contrast sensitivity in IPD patients within the lowest performance quartile. Controls showed a much stronger link between "fear" perception" and low contrast detection. Conclusion: At the early IPD stage there are marked deficits of LOV performances, while HOV performances are still intact, with the exception of reduced recognition of "sadness". At this stage, IPD patients seem still to compensate the deficient input of low contrast sensitivity, known to be pivotal for appreciation of negative facial emotions and confirmed as such for healthy controls in this study.
Introduction
Processing visual information occurs at two levels. The lower order vision (LOV) is involved in colour identification, contrast sensitivity and processing of line orientation. Higher order vision (HOV) is responsible for further processing visual input, leading to object recognition, space and motion perception, face identification, and facial emotion recognition (FER). During the early motor stage of idiopathic Parkinson's disease (IPD), patients regularly show LOV deficits. Standardized clinical tests supported by computer-driven evaluation, optical coherence tomography and neuroimaging techniques have convincingly shown that colour discrimination and contrast sensitivity are impaired [1] [2] [3] .
In terms of HOV, studies yield less conclusive results. IPD patients show impairment for space perception and object recognition [4] . However, most of the studies have been performed at an advanced stage of the disease. Controversy has also arisen concerning the recognition of facial expressions. While it is generally accepted that IPD patients may be most susceptible to misperception of negative emotions [5] [6] [7] , the causes of these deficits remain controversial. Potential contributing factors have been proposed such as male gender, predominant righthemisphere pathology, executive dysfunction, apathy, dopaminergic therapy or its withdrawal and deep brain stimulation of the nucleus subthalamicus [7] [8] [9] . At an early disease stage -the focus of interest of the present study -some authors have reported marked impairment [5] , others only mild restrictions [10] , or no deficit at all [11] . Evidently, other visuo-spatial deficits may play a substantial role as well, but have not been analysed as such. A potential important link is suggested by findings physiologically linking intact perception of low contrast to rapid recognition of negative emotional face expressions [12] .
Based on these findings we designed the present study and hypothesized that, at an early motor stage of IPD, patients may show impaired LOV, but would produce only mild deficits of HOV, especially in the domain of FER. So far no study has systematically investigated such potential links between LOV and FER at an early IPD stage.
Methods and materials

Subjects
Within an ongoing study on the evolution of non motor signs in early IPD [13] , we recruited 28 patients at a very early stage of the disease. Thus all patients had to satisfy to the strict inclusion criterion of equal or less than three years of disease duration. The diagnosis was established according to the UK Parkinson's Disease Society Brain Bank clinical diagnostic criteria [14] . Twenty-five healthy control subjects were recruited, mainly as spouses of IPD patients or by the mass media. Visual acuity was tested in all subjects, while wearing their best glasses and at a five meter distance from the board. All had normal visual acuity as assessed by a Snellen fraction N 0.6. In a standardized way all subjects were proactively and systematically asked about visual hallucinations and illusions. IPD patients were tested on their usual dopaminergic medication. All subjects gave informed written consent before entering the study. The study was approved by the National Ethical Research Committee of Luxembourg (CNER).
Methods
LOV evaluation
Contrast sensitivity was tested by two wall-mounted charts: Vistech test and Pelli Robson test. Colour discrimination was assessed by the Farnsworth-Munsell 100 Hue test.
In the Vis-tech test [15] chart photographs of sinusoidal gratings are presented and thresholds for different spatial frequencies are determined by the subject recognising the correct orientation of the stripes of the gratings varying in contrast. Subjects are placed at three meters from the chart. The test is performed in normal daylight conditions. For each of the five different spatial frequencies (1.5 cycles per degree (cpd), 3 cpd, 6 cpd, 12 cpd, 18 cpd), nine figures with decreasing contrasts are presented. Subjects have to determine the line orientation (to the left, right, up, down). The scores for each spatial frequency are the sum of correctly identified items (1) (2) (3) (4) (5) (6) (7) (8) (9) . In the Pelli-Robson test [16] standard sized letters of uniform spatial frequency are presented with decreasing contrast on a chart, as the subjects read along a line, allowing threshold detection. There are two triplets of letters per line, the contrast being decreased for each triplet. This chart is placed at one meter from the subjects and performed in normal daylight conditions. In the Farnsworth-Munsell 100 Hue test [17] , subjects have to place caps of different shades of colours in the right order. The test is performed under daylight conditions by using a special daylight lamp (Richmont Flat Tray True-Daylight Illuminator). The caps are arranged in four boxes, each containing a fixed anchor cap at each end. There are 4 colour axes: yellow, blue, green and red. For each colour axis an error score is calculated, following the manufacturer's recommendations and as similarly applied in other studies [13] .
FER evaluation
FER was evaluated with the Ekman 60 Faces Test (E60FT). This test explores six emotions: anger, fear, disgust, happiness, sadness, and surprise [18] . Subjects are placed in front of a computer screen where they are shown ,one by one, 60 greyscale photographs of faces expressing one of the six emotions. Subjects have to indicate which one of the six possible emotions is expressed. For each emotion, there are ten portraits expressing this emotion, so the possible score for each emotion ranges between 0 and 10.
Visual object perception (VOP)
Visual object perception was evaluated by part A of the Visual Object and Space Perception (VOSP) battery [19] . There are four subtests. In the subtest "incomplete letters" twenty letters that are partially degraded have to be identified. In the subtest "silhouettes" the participant has to identify 15 animal silhouettes and 15 inanimate object silhouettes, all presented in an unusual perspective. In the subtest "object decision" four objects are presented in a rotated manner; three are not real objects; the subject has to identify the one real object out of the four. Finally, in the subtest "progressive silhouettes", the subject has to identify a gun and a trumpet; both objects are presented as ten silhouettes that are initially abstract and progressively revealing more details.
Executive functions and sequencing of the tests
Executive functions were evaluated by the Frontal Assessment Battery (FAB) and motor sequencing by the Trail Making Test A (TMT A). The tests were administered by two experienced neuropsychologists (GH and VP) on two different days. FER and VOP were tested during the first session, FAB, TMTA and LOV during the second session. Importantly, in order to avoid reduction of the attention span, pauses were regularly inserted in the testing program.
Data analysis
The means between the two groups were compared by using ANOVA on raw values and by using the Mann-Whitney test. The interdependency between the test results within groups was analysed with Pearson correlation coefficients. We defined the values derived from the tests Farnworth-Munsell, Vis-tech and Pelli-Robson as primary outcome variables. For multiple comparisons we used the Hochberg comparison (1988) to correct the individual p values (proc multitest in SAS version 9.3).
Results
Descriptive demographics
Gender distribution was similar in both groups. IPD group: 15 women and 13 men; control group: 15 women and 10 men (NS). Age was similar in both groups: 62.49 +/− 11.9 years in the IPD group versus 59.57 +/− 7.4 years in the control group (p = 0.09). In IPD patients disease duration was 1.36 +/− 0.8 years and the score on the motor part of the Unified Parkinson Disease Rating Scale (UPDRS), while being "on" medication, was 8.39 +/− 3.52 [range: 0-25]. The mean daily levodopa dosage in the IPD patients was 198.4 ± 248.3 mg.
Cognitive performances
No subject had a pathological score on the MMSE and the mean values were: 28.8 ± 1.4 [range: [25] [26] [27] [28] [29] [30] for the IPD patients and 29.4 ± 0.7 [range: [28] [29] [30] for the controls (p = 0.03). No subject scored N0 at the Clinical Dementia Rating Scale (CDRS). No participant reported visual hallucinations. IPD patients had lower performances than controls on the FAB (15.46 +/− 1.57 vs. 17.08 +/− 0.95, p b 0.00001). They also performed more slowly on the TMT A test than the controls (42.8 ± 13.9 vs. 36.0 ± 10.8, p = 0.04).
3.3. LOV performances 3.3.1. Colour discrimination and contrast sensitivity (Table 1) The IPD patients performed worse than control subjects on all the LOV tests. Concerning colour discrimination, there was a significant difference for one of the four colour axes (red: p = 0.03). The total error score was higher in IPD patients than in control subjects, but not significantly, due to high variability. Concerning contrast sensitivity evaluated by Vistech, the highest difference concerned the lowest spatial frequency (1.5 cycles/degree: p = 0.0002). The IPD patients performed worse than control subjects on the Pelli-Robson test for binocular (p = 0.0002) vision only. All results are listed in Table 1 which, of note, contains only p values obtained after Hochberg correction for multiple comparisons.
HOV performances
Recognition of facial emotion and visual objects
In terms of object and space recognition, IPD patients and controls performed similarly (Table 1 ). Concerning FER, IPD patients performed worse than control subjects for the emotion "sadness" (IPD: 6.5 ± 2.3, controls: 8.0 ± 1.8; p = 0.01). There were no further significant differences between both groups (Fig. 1) . However it should be noted that IPD patients performed better on recognition of positive emotions and control subjects better on recognition of negative emotions.
Are HOV performances linked to LOV performances?
In the IPD group, we found no overall correlation between LOV and FER performances. However, the quartile of IPD patients with the lowest performances for "fear" recognition performed also worse than other IPD patients in the Vistech 12-test (p = 0.04) and the Pelli-Robsonleft test (p = 0.03). In contrast, in healthy controls perception of contrast sensitivity and colour discrimination was in general linked with the recognition of the negative emotion "fear" (Table 2 ). Such a link was not seen for other emotions, neither in control subjects nor in IPD patients (results not shown).
Potential confounders
In the IPD group, no correlation was found between age and LOV respectively FER, except for the recognition of surprise, which was linked to age (r = −0.4, p = 0.03). The levodopa medication was not correlated to LOV or FER. The gender of the IPD subjects had only an influence on fear recognition (males: 6.6 +/− 2.2, females: 4.4 +/− 2.8; p = 0.05), while all other FER and LOV performances were similar. Executive dysfunction represented by lower score on the FAB was only correlated with the recognition of anger (r = 0.5; p = 0.01). This link was maintained after Hochberg correction for test multiplicity. There was no influence of processing speed, expressed as TMT A score, on any outcome variable (results not shown).
Discussion
This study confirms marked deficits of colour discrimination and contrast sensitivity in IPD patients at a very early disease stage, with significant differences concerning the discrimination of colours within the red spectrum and the contrast sensitivity of sinusoidal gratings presented at the lowest spatial frequency. In contrast, most performances of high order vision are still intact. This applies in particular to the perception of facial emotion expression, with preserved recognition of all positive and most negative facial expressions, including disgust. Only perception of sadness is impaired. Furthermore IPD patients with the lowest performances concerning "fear" detection (lowest quartile) have also the lowest scores on contrast sensitivity. In contrast, but as predicted by literature [12] , healthy controls evidenced a general and robust link between perception of "fear" and performances in several HOV domains. Thus, our results confirm, to some extent, that a link between LOV and "fear" recognition exists in normal subjects, but this link is much looser in IPD patients. This discrepancy suggests that compensatory mechanisms are functional in IPD patients or that facial emotion processing is processed differently in IPD patients than in normal subjects. Before explicitly discussing these issues, it is worthwhile to, first, recapitulate the anatomical pathways involved in emotional face recognition and, second, to present in more detail the concept linking low contrast discrimination with emotional face recognition. 
Table 2
Correlations between different LOV performances and "fear" recognition in 28 IPD patients and in 25 control subjects. 
Anatomical pathways involved in facial emotion recognition
Lesion and neuroimaging studies have proposed that FER is mediated by pathways projecting to the inferior frontal area within the prefrontal cortex and to the temporo-parietal cortex [20, 21] . The amygdala, especially on the right side, is a pivotal relay station within the circuitry and functions as emotion regulation system [22, 23] . Of note, recognition of disgust also involves the basal ganglia [20] . This implication of basal ganglia and amygdala in FER suggests that IPD patients may be impaired in emotion recognition, at least in stage 3 according to Braak, which is the earliest motor stage of the disease and explored as such in the present study.
Linking low contrast sensitivity and facial emotion recognition
At first look it is difficult to explain why LOV performances shouldalso -be linked with facial emotion recognition. In short, low contrast sensitivity contributes to the "rapid glimpse" appreciation of negative emotions. This means that in normal adults the perception of the facially expressed emotions is mediated, in a first step, by the subcortical retinocolliculo-pulvinar-amygdala (RCPA) pathway [24] . This magnocellular pathway uses lower spatial frequencies for rapidly exploring the face expression. It avoids the slower visual pathway via the cortical area V1, which later induces a conscious emotion identification using high spatial frequencies [12, 25] . The RCPA is fully developed in the newborn [26] . It is thought to be a phylogenetically ancient pathway, "critical for survival", by allowing "expedient detection of fear-related cues through covert circuitries, in which the amygdala plays an essential role" [12] .
Is there a paradox between both concepts of FER, one linking FER with distinct anatomical brain regions, the other linking it with "basic" visual performances? Indeed, at first look, both pathways seem not to overlap. However FER can be subdivided into two processes:
(a) subconscious "identification" which can be categorized within the performances of the LOV rather than those of the HOV by its physiological properties; (b) conscious recognition of the emotion mediated by cortical brain structures and to be classified as HOV performance only.
Intact subcortical emotion processing facilitates the explicit emotion recognition by feedback processes between both, cortical and subcortical, pathways. It is, however, not an obligatory precondition [27] .
Why distinct deficits in IPD?
The just proposed dissection of FER into two distinct processes explains the seemingly dichotomy of the performances in early IPD patients. While healthy controls fully take advantage of the low contrast input when identifying a negative face expression, IPD patients mostly compensate for the deficient input of contrast detection. How could such compensatory mechanism function? Possibly, visual scanning of the face is used more extensively, and sustained fixations of the upper facial parts compensate the missing immediate appreciation [7] . A clue for such compensatory mechanisms at work is that in asymptomatic Parkin carriers functional MRI has evidenced increased activity in premotor areas acting as mirror neurons in those patients maintaining best performances in FER [28] . Furthermore, both pathways target the amygdala as "terminus", respectively as relay station. In IPD, cellular loss and high burden of Lewy bodies have been shown in particular in the amygdalar subnucleus called the cortical amygdaloid nucleus [29] . "Silent amygdala" or amygdala dysfunction has been proposed in IPD to be involved in odour misidentification, autonomic disturbances, and visual hallucinations. Reduced FER in IPD patients is thus a plausible finding. However, this reduction remains modest, sustaining the hypothesis that amygdala dysfunction in patients with IPD only modifies the neural pathways implicated in facial emotion recognition [27] . Finally, the fact that a link between LOV and HOV only appears in IPD patients most impaired in "fear" recognition, suggests, that only in these latter patients, compensatory strategies become insufficient, the reasons for this insufficiency being unknown.
Limitations of the study
Our study has several limitations. The LOV tests may be biased by reduced sustained attention, although we tried to control this variable by inserting pauses, other tests and questionnaires. IPD patients were tested, while being "on" their usual medication. It has been shown, that in non medicated patients colour discrimination and emotional face perception may be worse than in medicated patients [5] . We found no link between dopaminergic medication and visual performances. So, at worst, HOV deficits may be underestimated, but not overestimated in our cohort. The cohort size is relatively small and age differences may have influenced the results. In fact, it has been shown, that recognition of the negative emotions anger, fear and sadness decreases with age but not recognition of disgust, which seems to remain stable even with advanced age [30] . Finally, we did not perform a sub-analysis, comparing IPD patients with right-dominant basal ganglia pathology to IPD patients with left-dominant pathology.
Conclusions
This study directly compares for the first time deficits of lower order and higher order vision in IPD patients at a very early stage of the disease. Both parts of the visual system are already involved, but to a substantially different extent. Most IPD patients seem to efficiently compensate for LOV deficits when performing tests of HOV, in particular when recognizing facial emotions. Due to the inherent pathology of IPD, with both anatomical proof of amygdala involvement and psychophysiological proof of reduced low contrast perception, deterioration of facial emotion recognition seems, however, to be unavoidable on the long-term, with insufficient compensatory mechanisms in all patients, and not only some. Follow-up studies of the present cohort will be planned; confirmation in larger cohorts, possibly including ocular pursuit evaluation, is warranted.
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